USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ri.MED Foundation

USPTO PatentsView assignee record - 9 granted patents across 12 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ri.med ranks #29,942 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 12 technology areas.

#29,942
of 49,997 US assignees by volume
Top 34%
by Innovation Score (41.0/100)
16.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R29942 · Foreign Corporation #29,942 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #29,942/49,997
  • PHOTO-FINISH Research Cancer…
  • CPC-FOCUS A61L · 12 areas
  • INNOV-PAR 41.0/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Research Cancer Institute of America (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ri.med’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ri.med

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ri.med's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ri.med?

Each dot is one of Ri.med’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ri.med’s own 16.2 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ri.med vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 1015202530 Granted patents (volume) Avg claims / patent Research Cancer Institute of America - 9, 13.44Research Cancer I…Retrace Labs - 9, 17.67Retrace LabsRetrocausal, Inc. - 9, 19RetrocausalReverse Ionizer Systems, LLC - 9, 17.78Reverse Ionizer S…RideFlux Inc. - 9, 11.11RidefluxRimports, LLC - 9, 11.22RimportsRio Grande Neurosciences, Inc. - 9, 25.89Rio Grande Neuros…Riva Health, Inc. - 9, 13.22Riva HealthRi.MED Foundation - 9, 16.22Ri MED Foundation
Ri.med vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ri.med's grants concentrate

Ri.MED Foundation is a focused PatentsView assignee: 12 CPC subclasses with 55.6% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2022. By volume, Ri.med sits between Research Cancer Institute of America and Riva Health, Inc..

Ri.med's three-year grant acceleration

Ri.MED Foundation shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at RiMED's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ri.MED holds 9 patents at rank #29,931, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near RiMED

By rank, the assignees closest to #29,931 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in RiMED's primary technology class.

Ri.med's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20212022202320242025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Ri.MED Foundation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 3 33.3%
2022 1 11.1%
2023 1 11.1%
2024 3 33.3%
2025partial year 1 11.1%

Which technologies does Ri.MED Foundation patent most?

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ri.MED Foundation's patent record in context - here's where to go next.

  • Ri.MED Foundation's lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 55.6% of its portfolio - see every assignee active in that class. Explore A61L
  • Ranked #29,942 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ri.MED Foundation against Research Cancer Institute of America, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.